| abstract |
new variant of exendin and its conjugate. the invention provides a new variant of exendin and a conjugate of the variant of exendin that conjugates the polymer therein, the pharmaceutical composition comprising these and the use of these to treat diseases such as reduced blood glucose, to treat diabetes, especially type II diabetes. the invention also provides the use of the exendin conjugate to lower body weight. |